6-K ·Filed Jun 2, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor for any subsequent director appointments or changes in board composition, but this resignation alone is not a trading catalyst.
Final — all horizons settled through T+60d
CASIF ▲ +18.18% at T+60d
NEUTRAL call +18.18% · α vs SPY +17.06% · entry $0.1100 → $0.1300
T+1d
0.00%
call 0.00% · α +0.72%
$0.1100
settled 5mo ago
T+5d
-9.09%
call -9.09% · α -6.13%
$0.1000
settled 5mo ago
T+20d
+118.18%
call +118.18% · α +119.75%
$0.2400
settled 4mo ago
T+60d
+18.18%
call +18.18% · α +17.06%
$0.1300
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
CASI Pharmaceuticals disclosed the resignation of director Dr. Barbara Krebs-Pohl, effective May 31, 2026, with no disagreement cited. She will transition to an independent consultant role. This is a routine board change with no material financial or operational impact.
Key Facts
- Dr. Barbara Krebs-Pohl resigned as director effective May 31, 2026.
- Resignation was not due to any disagreement with the company.
- She agreed to serve as an independent consultant on mutually agreed terms.
- The filing is incorporated by reference into existing F-3 registration statements.
Financial Impact
No financial figures disclosed; no material impact.
Risk Factors
- Potential loss of board expertise or governance continuity if not replaced promptly.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-069177 |
| Document: 0001104659-26-069177-index-headers.html | 0001104659-26-069177 |
| Document: 0001104659-26-069177-index.html | 0001104659-26-069177 |
| Document: 0001104659-26-069177.txt | 0001104659-26-069177 |
10 reports for CASIF
67% Hit rate @ T+60 Went positive at some point 4 of 5 best @ T+1▲ +41.67%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 7w ago | 6-K | $0.1400 | awaiting T+60 | — | $0.1000 (−28.57%) |
Aug 14, 2026 10w ago | 6-K | $0.1500 | awaiting T+60 | — | $0.1000 (+33.33%) |
Jul 15, 2026 14w ago | 6-K | $0.1400 $0.1100 | ▼ −21.43% | ▼ −24.22% | $0.1000 (−28.57%) |
Jun 29, 2026 17w ago | 6-K | $0.1200 $0.1300 | ▲ +8.33% | ▲ +5.29% | $0.1000 (−16.67%) |
Jun 2, 2026 21w ago | 6-K | $0.1100 $0.1300 | ▲ +18.18% | ▲ +17.06% | $0.1000 (−9.09%) |
Apr 23, 2026 26w ago | 3 | $0.1300 $0.1700 | ▲ +30.77% | ▲ +25.75% | $0.1000 (−23.08%) |
Apr 20, 2026 27w ago | 6-K | $0.1700 $0.1344 | ▼ −20.94% | ▼ −27.84% | $0.1000 (−41.18%) |
Apr 20, 2026 27w ago | 6-K | $0.1700 $0.1250 | ▲ +26.47% | ▲ +33.25% | $0.1000 (+41.18%) |
Apr 15, 2026 27w ago | 6-K | $0.1500 $0.1451 | ▼ −3.27% | ▼ −11.40% | $0.1000 (−33.33%) |
Apr 3, 2026 29w ago | 3 | $0.1400 $0.2400 | ▲ +71.43% | ▲ +57.96% | $0.1000 (−28.57%) |
Showing 10 of 10
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers